News Foley Represents TCGX as Lead Investor in $127.5M Private Placement for Adverum Biotechnologies Foley & Larder LLP represented TCG Crossover (“TCGX”) as the lead investor in the $127.5…Louis LehotFebruary 13, 2024
News Foley Represents TCGX as Investor in $120M Private Placement for Silence Therapeutics Foley & Larder LLP represented TCG Crossover (“TCGX”) as an investor in the $120 million…Louis LehotFebruary 13, 2024
News Foley Represents TCGX as Lead Investor in $120M Private Financing for Mineralys Therapeutics Foley & Larder LLP recently represented TCG Crossover (“TCGX”) as a lead investor in the…Louis LehotFebruary 13, 2024
News Foley Represents TCGX as Investor in Tourmaline Bio, Concurrent with Merger with Talaris Therapeutics Foley & Lardner LLP represented TCGX as an investor in the $75 million private placement…Louis LehotJanuary 24, 2024
News Foley Represents TCGX as Co-Lead Investor in $150M Series B Financing for Alkeus Pharmaceuticals Foley & Lardner LLP represented TCGX as co-lead investor in the $150 million Series B…Louis LehotJanuary 23, 2024
News Louis Lehot Quoted on Health Care & Life Sciences Dealmaking Outlook Foley & Lardner LLP partner Louis Lehot is quoted in the Law360 article, “Attys Hopeful For Deals…Louis LehotJanuary 5, 2024
Blogs Strengthening the Flow of the Biotech Sector’s M&A Pipeline Originally published in Genetic Engineering News on October 10, 2023. Reprinted with permission. The biotechnology sector has long…Louis LehotOctober 23, 2023
Blogs The Importance of ESG for Startups: Pioneering a Sustainable Future Partners Louis Lehot and Michael Kirwan published an article in Reuters Legal News titled: “The Importance of…Louis LehotSeptember 29, 2023
News Foley Represents Bioluminescence Ventures as Lead Investor in ReCode Therapeutics Series B Funding Extension Foley & Lardner LLP represented Bioluminescence Ventures as the lead investor in the $50 million…Louis LehotSeptember 27, 2023
News Foley Represents TCGX as a Lead Investor in $285M Financing for COMPASS Pathways Foley & Lardner LLP represented TCGX as a lead investor in the $285 million financing…Louis LehotSeptember 6, 2023